Wilson Natalie, Ezeani Chukwunonso, Ismail Abdellatif, Abdalla Monzer, Mohammed Shaikhoon, Abdalla Abubaker, Elawad Ayman, Beran Azizullah, Jaber Fouad, Abosheaishaa Hazem, Loon Erica, Abdallah Mohamed, Vargo John, Bilal Mohammad, Chahal Prabhleen
Department of Internal Medicine, University of Minnesota Medical Center, Minneapolis, MN.
Department of Internal Medicine, Baton Rouge General Medical Center, Baton Rouge, LA.
J Clin Gastroenterol. 2025;59(5):472-478. doi: 10.1097/MCG.0000000000002029. Epub 2024 Jul 16.
This systematic review aims to evaluate the risk factors, clinical features, and outcomes of bowel perforation caused by stent migration after endoscopic retrograde cholangiopancreatography (ERCP).
Distal migration of biliary stents can occur after ERCP. Upon migration, most stents pass through the intestine without adverse events; however, bowel perforation has been reported.
A comprehensive literature search of PubMed, EMBASE, and Cochrane databases was conducted through October 2023 for articles that reported bowel perforation because of stent migration. Cases of incomplete stent migration and proximal stent migration were excluded. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines to identify full-length articles in English reporting.
Of 2041 articles retrieved on the initial search, 92 met the inclusion criteria. A total of 132 cases of bowel perforation occurred due to stent migration after ERCP (56.1% female; average age: 66 y). The median time from initial ERCP to perforation was 44.5 days (IQR 12.5-125.5). Most cases of perforation occurred in the small bowel (64.4%) compared with the colon (34.8%). Stents were mostly plastic (87.1%) with a median diameter of 10 Fr (IQR 8.5-10) and median length of 10.3 cm (IQR 715). Surgical management was pursued in 52.3% and endoscopic management in 42.4%. Bowel resection was required for 25.8% of patients. The overall mortality rate was 17.4%.
In summary, this study demonstrates that bowel perforation after ERCP stent migration primarily occurs within 44.5 days and most frequently with a 10 Fr plastic biliary stent. The overall mortality rate was 17.4%. It is important for endoscopists to be mindful of this rare but serious adverse event.
本系统评价旨在评估内镜逆行胰胆管造影术(ERCP)后支架移位导致肠穿孔的危险因素、临床特征及结局。
ERCP后胆管支架可能发生远端移位。移位时,大多数支架可穿过肠道而无不良事件发生;然而,已有肠穿孔的报道。
通过检索PubMed、EMBASE和Cochrane数据库,全面查找截至2023年10月报道因支架移位导致肠穿孔的文章。排除支架不完全移位和近端支架移位的病例。我们遵循系统评价和Meta分析的首选报告项目指南,以识别英文报道的全文文章。
在初始检索中检索到的2041篇文章中,92篇符合纳入标准。ERCP后因支架移位共发生132例肠穿孔(女性占56.1%;平均年龄:66岁)。从首次ERCP到穿孔的中位时间为44.5天(四分位间距12.5 - 125.5天)。与结肠(34.8%)相比,大多数穿孔病例发生在小肠(64.4%)。支架大多为塑料材质(87.1%),中位直径为10 Fr(四分位间距8.5 - 10),中位长度为10.3 cm(四分位间距7 - 15)。52.3%的患者采用手术治疗,42.4%采用内镜治疗。25.8%的患者需要行肠切除术。总体死亡率为17.4%。
总之,本研究表明,ERCP支架移位后肠穿孔主要发生在44.5天内,最常发生于10 Fr塑料胆管支架。总体死亡率为17.4%。内镜医师应注意这种罕见但严重的不良事件,这很重要。